The Full Wiki

Buerger's disease: Wikis

Advertisements
  
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Buerger's disease
Classification and external resources
ICD-10 I73.1
ICD-9 443.1
OMIM 211480
DiseasesDB 1762
eMedicine med/253
MeSH C14.907.137.870
Not to be confused with Berger's disease (IgA nephropathy)

Buerger's disease (also known as thromboangiitis obliterans) is a recurring inflammation and thrombosis (clotting) of small and medium arteries and veins of the hands and feet. It is strongly associated with use of tobacco products,[1] primarily from smoking, but also from smokeless tobacco.

Contents

Features

There is a recurrent acute and chronic inflammation and thrombosis of arteries and veins of the hands and feet. The main symptom is pain in the affected areas. Ulcerations and gangrene in the extremities are common complications, often resulting in the need for amputation of the involved extremity.

This disease was first reported by Buerger in 1908, who described a disease in which the characteristic pathologic findings — acute inflammation and thrombosis (clotting) of arteries and veins — affected the hands and feet. Another name for Buerger’s Disease is thromboangiitis obliterans.

Diagnosis

A concrete diagnosis of thromboangiitis obliterans is often difficult as it relies heavily on exclusion of other conditions. The commonly followed diagnostic criteria are below although the criteria tend to differ slightly from author to author. Olin (2000) proposes the following criteria:[2]

  1. Typically between 20–40 years old and male, although recently females have been diagnosed.
  2. Current (or recent) history of tobacco use
  3. Presence of distal extremity ischemia (indicated by claudication, pain at rest, ischemic ulcers or gangrene) documented by noninvasive vascular testing such as ultrasound
  4. Exclusion of other autoimmune diseases, hypercoagulable states, and diabetes mellitus by laboratory tests.
  5. Exclusion of a proximal source of emboli by echocardiography and arteriography
  6. Consistent arteriographic findings in the clinically involved and noninvolved limbs.

Buerger’s disease can be mimicked by a wide variety of other diseases that cause diminished blood flow to the extremities. These other disorders must be ruled out with an aggressive evaluation, because their treatments differ substantially from that of Buerger’s Disease. For Buerger’s there is no treatment known to be effective.

Diseases with which Buerger’s Disease may be confused include atherosclerosis (build–up of cholesterol plaques in the arteries), endocarditis (an infection of the lining of the heart), other types of vasculitis, severe Raynaud’s phenomenon associated with connective tissue disorders (e.g., lupus or scleroderma), clotting disorders of the blood, and others.

Angiograms of the upper and lower extremities can be helpful in making the diagnosis of Buerger’s disease. In the proper clinical setting, certain angiographic findings are diagnostic of Buerger’s. These findings include a “cock” appearance of arteries that result from vascular damage, particularly the arteries in the region of the wrists and ankles. Angiograms may also show occlusions (blockages) or stenoses (narrowings) in multiple areas of both the arms and legs. The changes are particularly apparent in the blood vessels in the lower right hand portion of the picture (the ulnar artery distribution).

In order to rule out other forms of vasculitis (by excluding involvement of vascular regions atypical for Buerger’s), it is sometimes necessary to perform angiograms of other body regions (e.g., a mesenteric angiogram).

Skin biopsies of affected extremities are rarely performed because of the frequent concern that a biopsy site near an area poorly perfused with blood will not heal well.

Pathophysiology

There are characteristic pathologic findings of acute inflammation and thrombosis (clotting) of arteries and veins of the hands and feet (the lower limbs being more common). The mechanisms underlying Buerger's disease are still largely unknown. It is suspected that immunological reactions play a role.

The association of Buerger’s Disease with tobacco use, particularly cigarette smoking, cannot be overemphasized. Most patients with Buerger’s are regular smokers but some cases occur in patients who only smoke “moderately”; others have been reported in users of smokeless tobacco. It has been postulated that Buerger’s Disease is an “autoimmune” reaction (one in which the body’s immune system attacks the body’s own tissues) triggered by some constituent of tobacco.

Treatment

Smoking cessation has shown to slow the progression of the disease and decrease the severity of amputation in most patients, but does not halt the progression.

Vascular surgery can sometimes be helpful in treating limbs with poor perfusion secondary to this disease. Use of vascular growth factor and stem cell injections have been showing promise in clinical studies.

Streptokinase has been proposed as adjuvant therapy in some cases.[3]

In addition Limaprost, an oral PGE1 derivative has shown efficacy in one recent randomized trial published in Spine vol 34

Spine: 15 January 2009 - Volume 34 - Issue 2 - pp 115–120 doi: 10.1097/BRS.0b013e31818f924d Randomized Trial The Efficacy of Prostaglandin E1 Derivative in Patients With Lumbar Spinal Stenosis Matsudaira, Ko; Seichi, Atsushi; Kunogi, Junichi; Yamazaki, Takashi; Kobayashi, Atsuki; Anamizu, Yorito; Kishimoto, Junji; Hoshi, Kazuto; Takeshita, Katsushi; Nakamura, Kozo http://journals.lww.com/spinejournal/Abstract/2009/01150/The_Efficacy_of_Prostaglandin_E1_Derivative_in.4.aspx

Prognosis

Buerger's is not immediately fatal, but life-shortening. Amputation is common and major amputations (of limbs rather than fingers/ toes) are almost twice as common in patients who continue to smoke. Death rate has not been consistently shown as higher in patients who do not cease smoking but for this and other health concerns quitting is highly recommended. Female patients tend to show much higher longevity rates than men.

Despite the clear presence of inflammation in this disorder, anti-inflammatory agents such as corticosteroids have not been shown to be beneficial in healing, but do have significant anti-inflammatory and pain relief qualities in low dosage intermittent form. Similarly, strategies of anticoagulation (thinning of the blood with aspirin or other agents to prevent clots) have not proven effective. The only way to slow the progression of the disease is to abstain from all tobacco products.

Prevention

The cause of the disease is unknown but thought to be autoimmune in nature and heavily linked to tobacco use. There have also been links to persons with digestive disorders.

Epidemiology

Buerger's is more common among men than women. It is more common in Israel, Japan and India along the "old silk route" than in the United States and Europe. The disease is most common among South Asians. The patients are almost always from low class of their society.

Famous Persons Diagnosed with Buerger's Disease

  • As reported by Alan Michie in "God Save The Queen," published in 1952 (see pages 194 and following), King George VI was diagnosed with the disease in late 1948 and early 1949. Both legs were affected, the right more seriously than the left. The King's doctors prescribed complete rest and electric treatment to stimulate circulation, but either unaware of the connection between the disease and smoking (the King was a heavy smoker), or unable to persuade the King to stop smoking, the disease failed to respond to their treatment. On March 12, 1949, the King underwent a lumbar sympathectomy, performed at Buckingham Palace by Dr. James R. Learmonth. The operation, as such, was successful, but the King was warned that it was a pallative, not a cure, and that there could be no assurance that the disease would not grow worse. From all accounts, the King continued to smoke.

History

Buerger's disease was first reported by Felix von Winiwarter in 1879 in Austria.[4]

It wasn't until 1908, however, that the disease was given its first accurate pathological description, by Leo Buerger at Mount Sinai Hospital in New York City.[5] Buerger called it "presenile spontaneous gangrene" after studying amputations in 11 patients.

Notes

  1. ^ Joyce JW (1990). "Buerger's disease (thromboangiitis obliterans)". Rheum Dis Clin North Am 16 (2): 463–70. PMID 2189162.  
  2. ^ Olin JW (Sep 2000). "Thromboangiitis obliterans (Buerger's disease)". N Engl J Med 343 (12): 864–9. doi:10.1056/NEJM200009213431207. PMID 10995867. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=10995867&promo=ONFLNS19.  
  3. ^ Hussein EA, el Dorri A (1993). "Intra-arterial streptokinase as adjuvant therapy for complicated Buerger's disease: early trials". International surgery 78 (1): 54–8. PMID 8473086.  
  4. ^ von Winiwarter F (1879). "Ueber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangran des Fusses". Arch Klin Chir 23: 202–26.  
  5. ^ Buerger L (1908). "Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene" (). Am J Med Sci 136: 567–80. http://www.amjmedsci.com/pt/re/ajms/pdfhandler.00000441-190810000-00011.pdf.  

References

  • Penile and scrotal involvement in Buerger's disease (p 401-403) T. Aktoz, M. Kaplan, O. Yalcın, I. H. Atakan, O. Inci, Published Online: Nov 25 2008 8:07PM DOI: 10.1111/j.1439-0272.2008.00859.x

External links

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message